PMGC Holdings Inc. (ELAB) Research
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.
Market snapshot
- Symbol
- ELAB
- Price
- $1.39
- Day change
- -2.80%
- Market cap
- $2.7M
- P/E ratio
- -0.06x
- 52-week range
- 1.34-309.89474
- Sector
- Healthcare
- Industry
- Biotechnology
Recent news
- What's Going On With PMGC Holdings Stock?
Shares of PMGC Holdings Inc. (NASDAQ: ELAB) are trading higher on Monday after the company announced one of its subsidiaries, NorthStrive Biosciences, transferred a key project to a U.S.-based third-party fermentation facility.
- Why PMGC Holdings Stock Is Falling Friday?
PMGC Holdings Inc. (NASDAQ: ELAB) shares faced downward pressure Friday. The stock dropped roughly 3.42% to $5.08 by midday.
- Why Is PMGC Holdings Stock Gaining Thursday?
AGA Precision expands defense role with new Tier 1 aerospace contract under parent PMGC Holdings (NASDAQ: ELAB).
Peer companies
Recent insider activity
- Parry Jeffrey — A-Award (75046 shares) on 2026-06-01
- Kovalyov George — A-Award (75046 shares) on 2026-06-01
- Daley Juliana — A-Award (75046 shares) on 2026-06-01
- Braeden Lichti — A-Award (450277 shares) on 2026-06-01
- Parry Jeffrey — trade (0 shares) on 2023-11-13
Open PMGC Holdings Inc. (ELAB) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.